Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 5, Pages 2659-2668
Publisher
American Chemical Society (ACS)
Online
2021-02-25
DOI
10.1021/acs.jmedchem.0c01779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function
- (2020) Sreekanth Rajan et al. Nature Chemical Biology
- The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs
- (2020) Sabine Willems et al. Communications Chemistry
- Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1
- (2020) Paola Munoz-Tello et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas
- (2019) Keshav Karki et al. JOURNAL OF NEURO-ONCOLOGY
- Apoptosis contributes to the cytotoxicity induced by amodiaquine and its major metabolite N-desethylamodiaquine in hepatic cells
- (2019) Yangshun Tang et al. TOXICOLOGY IN VITRO
- Uncoupling Stress-Inducible Phosphorylation of Heat Shock Factor 1 from Its Activation
- (2015) Marek A. Budzyński et al. MOLECULAR AND CELLULAR BIOLOGY
- Amodiaquine-induced reproductive toxicity in adult male rats
- (2015) Yan-Ru Niu et al. MOLECULAR REPRODUCTION AND DEVELOPMENT
- Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease
- (2015) Chun-Hyung Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist
- (2014) Daniel Merk et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of ligand efficiency metrics in drug discovery
- (2014) Andrew L. Hopkins et al. NATURE REVIEWS DRUG DISCOVERY
- NURR1 in Parkinson disease—from pathogenesis to therapeutic potential
- (2013) Mickael Decressac et al. Nature Reviews Neurology
- Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine
- (2012) Soon Goo Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2)
- (2010) Karen A. Nolan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Candidate Selection and Preclinical Evaluation ofN-tert-Butyl Isoquine (GSK369796), An Affordable and Effective 4-Aminoquinoline Antimalarial for the 21st Century
- (2009) Paul M. O’Neill et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started